Dna Biotech

With Bitcoin (BTC) surging above 5,000 in recent weeks, traders might be wondering whether now is the time to get back into altcoins. I’ve written in the past that the market will likely be more critical of blockchain-based projects in the future. There are two reasons for this.

The first reason is that many traders have suffered large losses during the past 16 months. Going forward, traders are only going to hold tokens of projects that they have a very high confidence level in. The second reason is that many projects have failed to live up to expectations. Companies and projects are going to face much more scrutiny as the cryptocurrency market matures. One company that continues to surpass expectations is Encrypgen (DNA).

The link for this article located at Hacked is no longer available.